M-195

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameM-195
Drug Alias NameMonoclonal antibody M195ZamylAclizumabSMART M195SMART M195 antibody +[7] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionImmunostimulants
TargetsMyeloid cell surface antigen CD33
Therapy Area/IndicationsMyelodysplastic SyndromesLeukemia, Promyelocytic, AcuteLeukemia, Myeloid, Acute +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPdl Biopharma IncAkzo Nobel +[3] 
Active IndicationsN/A
Inactive IndicationsMyelodysplastic SyndromesLeukemia, Promyelocytic, AcuteLeukemia, Myeloid, Acute +[4] 

Other Information

ATC CodeN/A
Related LinksN/A